Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
save search
Reviva Announces Full Details of Positive Phase 2 Clinical Trial Results for Acute Schizophrenia
Published: 2021-04-26 (Crawled : 11:00) - biospace.com/
RVPH | $3.315 -4.74% 78K
|
|
| O: 14.58%
H: 91.92%
C: 75.76%
phase 2 schizophrenia positive results trial trial results
Adial Provides Business Update Following Favorable Comments from US and EU Regulatory Meetings
Published: 2023-07-11 (Crawled : 12:20) - globenewswire.com
ADIL | $2.39 -8.43% 470K
|
Health Technology
|
| O: 8.4%
H: 155.36%
C: 75.56%
business favorable update
APDN Receives Largest Single Purchase Order for LinearDNA To Date
Published: 2022-10-10 (Crawled : 14:00) - adnas.com
APDN | $0.359 -0.33% 130K
|
Commercial Services
|
| O: -2.42%
H: 96.69%
C: 75.21%
order
Applied DNA Announces Receipt of Largest Single Purchase Order for LinearDNA™ To-Date
Published: 2022-10-10 (Crawled : 15:00) - biospace.com/
APDN | $0.359 -0.33% 130K
|
Commercial Services
|
| O: -2.42%
H: 96.69%
C: 75.21%
dna order
Endo Launches First Generic Version of Noxafil® (posaconazole) Injection
Published: 2023-06-29 (Crawled : 21:00) - prnewswire.com
ENDPQ 6 d | $0.0018 420K
|
n/a
|
| O: -55.56%
H: 125.0%
C: 75.0%
noxafil injection
Summit Therapeutics Partners with Akeso Inc. in Deal for Up to $5 Billion to In-License Breakthrough Innovative Bispecific Antibody$500 Million Upfront Payment to Activate the Partnership for Ivonescimab
Published: 2022-12-06 (Crawled : 13:00) - biospace.com/
SMMT | $3.5 -4.5% 360K
|
Health Technology
|
| O: 68.15%
H: 77.27%
C: 75.0%
partnership deal therapeutics payment
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF)
Published: 2022-12-06 (Crawled : 13:20) - prnewswire.com
SMMT | $3.5 -4.5% 360K
|
Health Technology
|
| O: 68.15%
H: 77.27%
C: 75.0%
global collaboration commercialization license therapeutics agreement
Gorilla Technology Group Reports Results Through Third Quarter 2023
Published: 2024-02-05 (Crawled : 13:00) - globenewswire.com
GRRR | $5.81 8.6% 580K
|
n/a
|
| O: 12.59%
H: 104.8%
C: 74.4%
group technology results
Pioneer Power Launches E-Boost© - Smart, Mobile EV Charging Solutions
Published: 2021-11-08 (Crawled : 13:15) - prnewswire.com
PPSI | $3.82 2.97% 95K
|
Producer Manufacturing
|
| O: 84.31%
H: 107.68%
C: 73.62%
mobile charging
Coinllectibles' Sales Ramp into 4Q as the "Magnificent Ceramic Series" Launched Last Month, was Sold Out for over US$3.8 Million
Published: 2022-10-25 (Crawled : 12:20) - prnewswire.com
COSG | $0.0001 0.0% 7.7M
|
Information
|
| O: -15.19%
H: 73.61%
C: 73.47%
sales
Vaxart, Inc. Signs Memorandum of Understanding with Attwill Medical Solutions Sterilflow, LP
Published: 2020-06-25 (Crawled : 09:36) - globenewswire.com
VXRT | $0.883 -2.87% 520K
|
Health Technology
|
| O: 13.17%
H: 79.5%
C: 73.41%
C4 Therapeutics Announces Positive Data from CFT7455 Phase 1 Trial in Relapsed/Refractory Multiple Myeloma
Published: 2023-12-12 (Crawled : 21:00) - globenewswire.com
CCCC | $6.84 -0.29% 650K
|
Health Technology
|
| O: 35.9%
H: 89.62%
C: 73.27%
cft7455 positive trial therapeutics
Benitec Biopharma Inc. Announces Pricing of $30 Million Underwritten Public Offering
Published: 2023-08-09 (Crawled : 03:00) - globenewswire.com
BNTC | $4.91 2.5K
|
Health Technology
|
| O: -2.62%
H: 160.22%
C: 72.04%
offering biopharma
CISO Global Participates in Microsoft Security Copilot Partner Private Preview
Published: 2023-11-15 (Crawled : 17:00) - globenewswire.com
CISO | $1.2 30K
|
|
| O: -2.72%
H: 141.4%
C: 72.04%
security global
Esports Entertainment Group Announces Update to Voluntary Delisting from the Nasdaq
Published: 2024-02-20 (Crawled : 18:00) - globenewswire.com
GMBL | $0.78 6.9K
|
Consumer Services
|
| O: -19.35%
H: 73.33%
C: 72.0%
nasdaq entertainment update group
Initial Data from Ongoing Phase 1 Trial of VIR-3434 for Chronic Hepatitis B Virus Infection Demonstrates Significant and Rapid Reduction in Hepatitis B Surface Antigen
Published: 2021-01-26 (Crawled : 13:03) - globenewswire.com
VIR | $8.475 -1.11% 190K
|
Health Technology
|
| O: 1.37%
H: 73.96%
C: 71.96%
hepatitis trial phase 3 phase 1 phase 2 injection ongoing infections chronic hepatitis b
Selina Management Reaffirms Its Confidence In Its Strategy and Highlights Alignment with Shareholders Through Equity Ownership in the Company
Published: 2024-04-09 (Crawled : 10:00) - globenewswire.com
SLNA | $0.0626 -11.08% 5.1M
|
n/a
|
| O: 14.25%
H: 154.92%
C: 71.77%
management company
Digital Locations Announces Disruptive Satellite-to-Smartphone Technology
Published: 2023-06-08 (Crawled : 15:20) - globenewswire.com
DLOC | $0.0027 1.3M
|
Manufacturing
|
| O: 40.0%
H: 85.71%
C: 71.43%
technology
Ehave Plans Stock Distribution; Mycotopia Therapies Plans To Merge With Ei. Ventures
Published: 2021-12-08 (Crawled : 13:30) - globenewswire.com
EHVVF | $0.001 34K
|
Professional, Scientific, and T...
|
| O: 6.67%
H: 125.0%
C: 71.25%
distribution merge therapy
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
Published: 2023-12-18 (Crawled : 13:00) - globenewswire.com
PBLA | $0.54 79K
|
Professional, Scientific, and T...
|
| O: 29.1%
H: 177.92%
C: 71.16%
approval therapeutics
Gainers vs Losers
| 54% | 46% |
Top 10 Gainers
WISA 4 | $7.86 349.14% 120M
|
Electronic Technology
TPET | $0.4951 114.24% 29M
|
n/a
JAGX | $0.1771 49.07% 540M
|
Health Technology
SXTC | $2.03 45.0% 27M
|
Health Technology
SPCB | $0.3888 40.87% 27M
|
Electronic Technology
DYNT | $0.52 40.39% 20M
|
Health Technology
SNGX | $0.54 39.86% 7.3M
|
Health Technology
BSGM | $1.53 39.09% 2.6M
|
Health Technology
MCBC | $13.74 38.37% 1.6M
|
Finance
PALI | $5.51 32.45% 28M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.